相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults
Kevin M. Gray et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial
Frances R. Levin et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone
Adam Bisaga et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers
Margaret Haney et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Reliability of the Timeline Followback for Cocaine, Cannabis, and Cigarette Use
Sean M. Robinson et al.
PSYCHOLOGY OF ADDICTIVE BEHAVIORS (2014)
A Double-Blind Randomized Controlled Trial of N-Acetylcysteine in Cannabis-Dependent Adolescents
Kevin M. Gray et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans
Mohini Ranganathan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
A Proof-of-Concept Randomized Controlled Study of Gabapentin: Effects on Cannabis Use, Withdrawal and Executive Function Deficits in Cannabis-Dependent Adults
Barbara J. Mason et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Naltrexone Depot Formulations for Opioid and Alcohol Dependence: A Systematic Review
Philipp P. Lobmaier et al.
CNS NEUROSCIENCE & THERAPEUTICS (2011)
Opioid antagonism enhances marijuana's effects in heavy marijuana smokers
Ziva D. Cooper et al.
PSYCHOPHARMACOLOGY (2010)
Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate-Dependence
Wilfrid Noel Raby et al.
AMERICAN JOURNAL ON ADDICTIONS (2009)
The therapeutic alliance in medical-based interventions impacts outcome in treating alcohol dependence
W. D. Dundon et al.
DRUG AND ALCOHOL DEPENDENCE (2008)
The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice
Arash Bahremand et al.
EPILEPSY RESEARCH (2008)
Opioid antagonism of cannabinoid effects: Differences between marijuana smokers and nonmarijuana smokers
Margaret Haney
NEUROPSYCHOPHARMACOLOGY (2007)
New insights into the efficacy of naltrexone based on trajectory-based reanalyses of two negative clinical trials
Ralitza Gueorguieva et al.
BIOLOGICAL PSYCHIATRY (2007)
Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone
JL Dunbar et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2006)
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors
M Kathmann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Ultra-low dose naltrexone enhances cannabinoid-induced antinociception
J Paquette et al.
BEHAVIOURAL PHARMACOLOGY (2005)
The COMBINE SAFTEE: A structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field
BA Johnson et al.
JOURNAL OF STUDIES ON ALCOHOL (2005)
Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats
M Solinas et al.
PSYCHOPHARMACOLOGY (2005)
The opioid antagonist naltrexone reduces the reinforcing effects of Δ9-tetrahydrocannabinol (THC) in squirrel monkeys
Z Justinova et al.
PSYCHOPHARMACOLOGY (2004)
Interaction between naltrexone and oral THC in heavy marijuana smokers
M Haney et al.
PSYCHOPHARMACOLOGY (2003)
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system
D Braida et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Naltrexone does not block the subjective effects of oral Δ9-tetrahydrocannabinol in humans
SR Wachtel et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Antinociceptive, subjective and behavioral effects of smoked marijuana in humans
MK Greenwald et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
分享论文
